Generated by Rank Math SEO, this is an llms.txt file designed to help LLMs better understand and index this website.

# Charter Medical: Charter Medical is more than a single-use solutions supplier - we're a design partner. While we develop portfolio solutions that can be used off the shelf, Charter specializes in customizing single-use solutions to meet biopharma companies' unique processing needs, whether simple or complex.

## Sitemaps
[XML Sitemap](https://chartermedical.com/sitemap_index.xml): Includes all crawlable and indexable pages.

## Posts
- [How to Identify Optimal Materials for Biopharma Single-use Solutions](https://chartermedical.com/biopharma-single-use-solutions-material-selection/)
- [Neonatal Syringe Set with 40μm Filter](https://chartermedical.com/neonatal-syringe-set-with-40%ce%bcm-filter/): Charter Medical’s Neonatal Syringe Set with 40μm filter is designed for the removal of microaggregates and particulate debris from whole blood and red blood cells (RBC) during infusion. Syringe aliquots of RBC and plasma must be administered to a patient within 24 hours and syringe platelet aliquots within 4 hours.
- [Neonatal Syringe Set with 150μm Filter](https://chartermedical.com/neonatal-syringe-set-with-150%ce%bcm-filter/): The Charter Medical Neonatal Syringe Sets with 150μm filter is designed to prepare and deliver small aliquots of filtered whole blood, red blood cells, platelets, and fresh frozen plasma for neonatal/pediatric transfusion. Features & Benefits Needleless design to prevent accidental needle sticks, which complies with OSHA requirements and national needle stick safety laws Provides final filtration in accordance with Association for the Advancement of Blood & Biotherapies (AABB) blood administration requirements Provides closed blood-delivery system Maintains primary unit expiration date Maximizes usage of adult-size blood units Limits neonatal donor exposure Reduces aliquot preparation costs Filter hold-up volume is less than 5 mL Available in multiple syringe configurations and sizes Registered medical device 150μm Data Sheet Ordering Information (150μm Filter) Catalog #DescriptionCase Qty. 03-960-00Blood administration set with 150-micron filter and 30cc BD™ syringe24 03-960-10Blood administration set with 150-micron filter and 50cc BD™ syringe24 03-960-10X3Blood administration set with three (3) 150-micron filters and three (3) 50cc BD™ syringes24 03-960-32Blood administration set with 150-micron filter, syringe adapter, and minimal tubing48 03-960-33Blood administration set with 150-micron filter and syringe adapter48 03-960-34Blood administration set with 150-micron filter and spike port48 03-960-35Blood administration set with 150-micron filter and 35cc MONOJECT® syringe24 03-960-37Blood administration set with 150-micron filter and 60cc MONOJECT® syringe24 03-960-62Blood administration set with 150-micron filter and luer adapters, Y-type design48 03-BDP-30Blood administration set with 150-micron filter, 150 mL aliquot bag, and 30cc BD™ syringe18 03-BDP-60Blood administration set with 150-micron filter, 150 mL aliquot bag, and 50cc BD™ syringe18 03-MJP-60Blood administration set with 150-micron filter, 150 mL aliquot bag, and 60cc MONOJECT® syringe18 Ordering Information (150μm Filter - DEHP-free) Catalog #DescriptionCase Qty. 03-960-00FBlood administration set with 150-micron filter and 30cc BD™ syringe24 03-960-10FBlood administration set with 150-micron filter and 50cc BD™ syringe24 03-960-10FXBlood administration set with 150-micron filter, dockable access only, and 50cc BD™ syringe24 03-960-33FBlood administration set with 150-micron filter and syringe adapter48 03-960-35FBlood administration set with 150-micron filter and 35cc MONOJECT® syringe24 03-960-37FBlood administration set with 150-micron filter and 60cc MONOJECT® syringe24 03-960-37FXBlood administration set with 150-micron filter, dockable access only, and 60cc MONOJECT® syringe24
- [AccuStrain™ 40μm & 150μm Filters](https://chartermedical.com/accustrain-40%ce%bcm-150%ce%bcm-filters/): AccuStrain™ 40μm & 150μm Filters are designed and packaged for bioprocessing applications, providing filtration of cell aggregates and extraneous particulate removal in cell separation, media preparation, and final fill workflows.
- [Case Study: Leveraging Single-use Solutions to Solve Working Cell Bank Challenges](https://chartermedical.com/case-study-leveraging-single-use-solutions-to-solve-working-cell-bank-challenges/): A customer was looking for a more streamlined method to overcome three challenges to develop the formulation and filling processes for their cryopreserved working cell bank:
- [CryoProtect™ Bio-Containers](https://chartermedical.com/cryoprotect-bio-containers/): ​Charter Medical’s CryoProtect™ Bio-Containers are designed for storage, intermediate steps, final fill, and transport in bioprocessing applications.
- [DEHP-free Fluid Transfer Bags](https://chartermedical.com/dehp-free-fluid-transfer-bags/): Charter Medical's DEHP-free Fluid Transfer Bags are designed and packaged specifically for bioprocessing applications, storage, and transport of sterile fluids.
- [Four Common Types of Cryogenic Studies for Advanced Therapies](https://chartermedical.com/four-common-types-of-cryogenic-studies-for-advanced-therapies/): Cryopreservation is an indispensable part of bioprocessing and the manufacture of advanced cell and gene therapies. However, the success of cryopreservation heavily depends on the construction of single-use bags and components used to bring these life-saving therapies to patients. Biopharma manufacturers need these single-use solutions built to applicable specifications so they can withstand the harsh conditions of low- and ultra-low temperatures.
- [John Witkowski Appointed President & CEO of Solesis](https://chartermedical.com/john-witkowski-appointed-president-ceo-of-solesis/): TELFORD, PA — April 8, 2024  
- [Charter Medical’s Innovation Hub Joins Innovation Quarter](https://chartermedical.com/charter-medicals-innovation-hub-joins-innovation-quarter/): WINSTON-SALEM, N.C. — March 27, 2024 — Winston-Salem-based Charter Medical announced today it has established its new Innovation Hub in downtown Winston-Salem’s Innovation Quarter.
- [Solesis to Open First Manufacturing Site in Costa Rica Dedicated to Custom Polymer and Textile Healthcare Solutions](https://chartermedical.com/solesis-to-open-first-manufacturing-site-in-costa-rica-dedicated-to-custom-polymer-and-textile-healthcare-solutions/): Telford, PA—Solesis, a leader in the custom design, development, and manufacturing of textile- and polymer-based healthcare solutions for the medical device and biopharmaceutical industries, has announced plans to build a new manufacturing site in Costa Rica. This is the first site dedicated to producing implantable textile components, polymer-based devices and components, and single-use technologies. The Solesis family of companies is comprised of Secant Group, Polyzen, Charter Medical and SanaVita Medical, who together enable technologies and therapies for next-generation patient care.
- [How to Build a Process for Scale and Efficiency: Tips for a Designing a Single-use Manifold for Advanced Therapies](https://chartermedical.com/how-to-build-a-process-for-scale-and-efficiency-tips-for-a-designing-a-single-use-manifold-for-advanced-therapies/): By Jay Collins, Product Manager, Single-use; and Chris Hofmann, Single-use Design Engineer, Charter Medical LLCOctober 30, 2023
- [How Single-use Cryopreservation Solutions Enable Biopharmaceutical Manufacturing](https://chartermedical.com/how-single-use-cryopreservation-solutions-enable-biopharmaceutical-manufacturing/): October 20, 2023
- [Selecting The Right Single-Use Materials In Biopharmaceutical Manufacturing](https://chartermedical.com/selecting-the-right-single-use-materials-in-biopharmaceutical-manufacturing/): Single-use solutions must be constructed from bio-inert (i.e., biocompatible) materials to avoid adverse reactions with the cell-based fluids they come into contact with, and ultimately, the patient. Chemical composition is also critical. Biopharmaceutical manufacturers should look for a low extractable profile in the materials they select to reduce the risk of leachables that could significantly impact the final product. Certain additives like phthalates found in single-use materials such as DEHP can leach into the fluid during formulation, transfer, and storage, potentially disrupting typical cellular mechanisms.
- [Single-use Manufacturing: Prioritizing Particulate Control for Safer Therapy Development](https://chartermedical.com/single-use-manufacturing-prioritizing-particulate-control-for-safer-therapy-development/): By Jessica Harvey, Supervisor, Quality Control Analytics, Charter Medical, LLCAugust 10, 2023
- [Syringe Sets with 150-micron Filter – VERSION F](https://chartermedical.com/syringe-set-with-150-micron-filter/): Charter's Version F Neonatal Syringe Sets are DEHP-free for needleless blood draws with 150uM filtration.
- [Freeze-Pak™ Cryogenic Containers with FP-FLEX™ Tubing – Versions A and C](https://chartermedical.com/dehp-free-freeze-pak-with-fp-flex/): Charter's Version A Freeze-Pak™ cryogenic bags with FP-FLEX™ tubing are DEHP-free storage solutions for freezing applications.
- [The Single-Use Supply Chain: How To Avoid Surprises And Navigate Change](https://chartermedical.com/the-single-use-supply-chain-how-to-avoid-surprises-and-navigate-change/): Even as the COVID-19 pandemic recedes, the supply chain difficulties it created have persisted. As suppliers at all levels of the biopharma supply chain ecosystem recover, global demand for most biopharma materials continues to grow, creating widespread competition for those materials and supply chain challenges. Now more than ever, effective collaboration and communication between single-use solution (SUS) suppliers and biopharma customers will guide supply chain success.
- [Manifolding For Scale-Up, Safety, And Speed](https://chartermedical.com/manifolding-for-scale-up-safety-and-speed/): Single-use solutions (SUS) offer numerous benefits to bioprocessing and advanced therapy manufacturing. However, filling individual bags with media, buffers, cells or bulk product like viral vectors one at a time is a burdensome, time-consuming process. Single-use (SU) manifolds provide a solution by enabling seamless transition from filling single to multiple bags at once, as well as allowing for continuous, unrestricted flow of both process and product. Implementing a new process utilizing manifolds can initially seem daunting, but understanding how implementation is accomplished, as well as how an experienced partner eases the transition, can guide organizations’ decision-making on process enhancements.
- [Choosing Safer Single-use Materials to Enhance Advanced Therapy Manufacturing](https://chartermedical.com/choosing-safer-single-use-materials-to-enhance-advanced-therapy-manufacturing/): Advanced therapies are a crucial component of an emerging pharmaceutical toolbox. These new and novel drugs are often the last line of treatment for patients with rare and intractable diseases. As such, they require complex production processes to ensure they can address patient needs at the right time. As key players in enabling the design and development of these fragile, potentially life-saving biologic drugs, single-use technology (SUT) suppliers must align with advanced therapy manufacturers to de-risk single-use manufacturing processes and chemical composition requirements to maintain the safety and efficacy of new treatment innovations.
- [Advancements to Explore the Role of Biomaterials in Cell Therapy and Medical Device Innovation](https://chartermedical.com/advancements-to-explore-the-role-of-biomaterials-in-cell-therapy-and-medical-device-innovation/): Jupiter, FL - Advancements with Ted Danson will examine the role biomaterials play in healthcare innovation in a new segment, airing Saturday, May 20, at 8:00 pm ET, on Bloomberg.
- [Cell Expansion Containers](https://chartermedical.com/cell-expansion-containers/): Charter Medical’s Cell Expansion Containers (CXP) are designed for the expansion and culture of non-adherent cells. Cell Expansion Containers can be used to harvest, expand, and transfer cell cultures typically used in cell therapy research and commercial applications. The DEHP-free container has a single-layer polyolefin gas-permeable film and integrated tubing that allows for closed-system filling, feeding, and sampling.
- [Resolving Common Single-Use Concerns: Shaping Innovative Solutions for Cell Therapies](https://chartermedical.com/resolving-common-single-use-concerns-shaping-innovative-solutions-for-cell-therapies/): When cell therapies emerged more than a decade ago, solutions providers considered them more of a small, niche market, and therefore tended to invest resources in other areas. Manufacturers often repurposed tools from other industries for their cell therapy processes. Single-use solutions are examples of the tools that have evolved to meet the unique challenges of these therapies.
- [Solesis Expands Film & Coating Capabilities with Acquisition of Polyzen](https://chartermedical.com/solesis-aquires-polyzen/): Telford, PA - November 2, 2022—Solesis, parent company of Charter Medical, announced today that it has acquired Polyzen, LLC, a leading developer and manufacturer of polymer-based film and coating technologies for the medical device and biopharmaceutical industries. The addition of Polyzen will expand Solesis’ design and manufacturing capabilities in advanced biomaterials and broaden the service offering it delivers to its customers.
- [Streamline Therapeutic Development by Overcoming Single-Use Customization Misconceptions](https://chartermedical.com/streamline-therapeutic-development-by-overcoming-single-use-customization-misconceptions/): Contrary to popular belief, custom single-use solutions aren’t always complex, costly, and disruptive. While standard solutions may seem easy and guaranteed to work in any situation, they often create challenges in manufacturing workflows. For example, standard connectors, tubing, or other components can cause compromised sterility and labor-intensive operator procedures. Still, therapeutic developers often default to using standard single-use solutions based on industry-wide misconceptions about the complexity, costs, supply risks, and lead times of custom solutions. In some cases, developers adopt standard products simply because they are unaware of customization options. Not only do custom single-use options exist for many applications, but they can be both straightforward and cost-effective.
- [Freeze-Pak™ Bio-Containers](https://chartermedical.com/freeze-pak-bio-containers-2/): ​Charter Medical’s Freeze-Pak™ Bio-Containers are ideal to use in applications for final product frozen storage, bioprocessing, cell and gene therapy, and working and master cell banks.
- [Pooling Harness Sets](https://chartermedical.com/pooling-harness-sets/): Component Processing Charter Medical’s disposable multi-lead harness sets are designed for...
- [Blood Transfer Bags](https://chartermedical.com/blood-transfer-bag/): Blood transfer bags permit the sterile transport and storage of blood components. Constructed of PVC, they are available in a range of sizes and configurations.
- [Plasma/Fluid Transfer Sets](https://chartermedical.com/plasma-fluid-transfer-sets/): Disposable plasma/fluid transfer sets are designed to obtain a sample of blood or blood components and/or to perform a sterile transfer of blood or blood components from one container to another.
- [Freeze-Pak™ STS](https://chartermedical.com/freeze-pak-sts/): Freeze-Pak™ STS (FP-STS) Storage and Transport Solution Bio-Containers are designed for ultra-low temperature frozen storage and transport applications. FP-STS single-use containers offer robust performance to -80°C while the Freeze-Pak™ film itself is rated to temperatures as low as -196°C. FP-STS containers are suitable for long-term storage of cellular and non-cellular materials.
- [Bio-Pak<sup>®</sup> Small Volume Bio-Containers](https://chartermedical.com/bio-pak-small-volume-bio-container-systems/): Bio-Pak Small Volume bio-containers are designed for bioprocessing applications, storage, and transport of sterile fluids. Bio-Pak Small Volume bio-containers are available in sizes ranging from 50mL to 20L. Custom boat port designs facilitate excellent recovery of vital fluids.
- [Freeze-Pak™ Bio-Containers](https://chartermedical.com/freeze-pak-bio-containers/): Freeze-Pak™ Bio-containers are designed for use in ultra-low temperature applications. This film is a single web 12 mil polyolefin monolayer that does not contain an integral gas barrier.
- [Platelet Sampling Sets](https://chartermedical.com/platelet-sampling-sets/): Charter Medical provides solutions for transferring platelet samples safely from an automated apheresis unit or whole blood derived units to an automated bacterial culture system’s vacuum bottles.
- [Aliquot Bag Systems](https://chartermedical.com/aliquot-bag-systems/): Multiple-bag aliquot systems are designed to facilitate the collection, storage, processing, transport, separation, and administration of blood and blood components for neonatal or pediatric transfusion. Platelet component aliquots must be administered to a patient within 4 hours.
- [Plasma Processing Bags](https://chartermedical.com/plasma-processing-bags/): Charter Medical’s apheresis plasma aliquot systems, consisting of three 300/400 mL PVC bags each, may be attached to a jumbo plasma unit collected on an apheresis machine, allowing the jumbo plasma unit to be divided into three smaller units.
- [Advect<sup>®</sup> Fluid Transfer Sets](https://chartermedical.com/advect-fluid-transfer-sets/): Charter Medical’s Advect® Fluid Transfer Sets are intended for sterile transfer of bone marrow mononuclear cells from one container to another. The Advect® fluid transfer sets are provided sterile (fluid path) by gamma irradiation and intended for single use.
- [EXP-Pak™ Cell Expansion Containers](https://chartermedical.com/exp-pak-cell-expansion-containers/): Charter Medical’s EXP-Pak™ Bio-Containers are intended for the expansion and culture of non-adherent cells...
- [Bioprocessing Fluid Transfer Sets](https://chartermedical.com/fluid-transfer-sets/): Bring your biopharma processes together seamlessly. Charter Medical’s extensive range of standard and custom fluid transfer sets are optimized for bioprocessing and sterile transfer of media, biologics, and drug substances from one container to another.
- [Freeze-Pak™ with FP-FLEX™](https://chartermedical.com/fp-flex/): Freeze-Pak™ Bio-Containers with FP-FLEX™ Tubing
- [Cell Freeze<sup>®</sup> Cryogenic Storage Containers](https://chartermedical.com/cell-freeze-cryogenic-storage-container/): ​Charter Medical’s Cell Freeze® cryogenic storage containers are designed for storage, preservation, and transfer of hematopoietic cells (HPC) in liquid nitrogen to -196ºC. The Cell Freeze® Liquid Nitrogen Freezing Container is provided sterile (fluid path) by gamma irradiation and intended for single use. Do not reuse. Reuse causes contamination of the interior fluid path.
- [Fluid Transfer Bags](https://chartermedical.com/fluid-transfer-bag-systems/): Charter Medical Fluid Transfer Bag Systems are designed and packaged specifically for bioprocessing applications, storage, and transport of sterile fluids. These containers are available individually or in double Tyvek® Pouches. Sizes range from 150mL to 3L. Industry-standard 0.160” OD x 0.114” ID PVC tubing facilitates easy sterile connection to source container of like materials. Cleanroom-friendly packaging supports transfer into the cleanroom environment.
- [Direct Inoculum of Bioreactors with CHO Cells from Frozen Seed Bags to Eliminate Continual Seed Trains and Improve Facility Utilization](https://chartermedical.com/direct-inoculum-of-bioreactors-with-cho-cells-from-frozen-seed-bags-to-eliminate-continual-seed-trains-and-improve-facility-utilization/): Why did you decide to investigate the use of frozen seed bags for your seed train process?The use of frozen seed bags combined with single use technologies can significantly reduce startup timeline for perfusion bioreactor experiments and at the same time help achieve steady state high cell density significantly faster than that achieved using seed train when a high cell density inoculation strategy is adopted.
- [Filling Industry Gaps with Dedicated Cell Therapy Fluid Transfer Sets](https://chartermedical.com/filling-industry-gaps-with-dedicated-cell-therapy-fluid-transfer-sets/): Charter Medical’s Advect® Fluid Transfer Sets have been designed to support the global quality and manufacturing requirements of the cell therapy industry. Compared with other currently available products which were designed for other industries (i.e., blood transfusion), Advect products are medical devices designed to help facilitate seamless global technology transfer for clinical and commercial production of cell therapies and personalized medicine.
- [Cool Tool – Particulates in Cell Therapy Products – An important issue for commercialization](https://chartermedical.com/cool-tool-particulates-in-cell-therapy-products-an-important-issue-for-commercialization/): The presence of particulates in cell therapy products is an issue that is becoming increasingly important as potential cell therapies move through the clinical pipeline. I recently read a very informative paper on this topic titled, “Managing Particulates in Cell Therapy: Guidance for Best Practice,” published in Cryotherapy and written by the International Society for Cellular Therapy (ISCT) Process and Product Development Subcommittee (Clarke, et al.). The paper was written to provide guidance for cell therapy developers, manufacturers and also suppliers regarding the management of particulates in cell therapy products.
- [Cell Therapy Manufacturing & Gene Therapy Congress](https://chartermedical.com/cell-therapy-manufacturing-gene-therapy-congress/): December 2 – 3, 2015 Sheraton Airport Hotel Brussels, Belgium BOOTH #17
- [BioProduction 2015](https://chartermedical.com/56/): October 14-15, 2015 Citywest Hotel Conference & Events Center Dublin, Ireland Booth #22

## Pages
- [Terms of Use](https://chartermedical.com/terms-of-use/): Acceptance of the Terms of Use
- [Platelet Sampling Sets](https://chartermedical.com/platelet-sampling-sets/): Charter Medical provides solutions for transferring platelet samples safely from an automated apheresis unit or whole blood derived units to an automated bacterial culture system’s vacuum bottles.
- [Filtration](https://chartermedical.com/filtration-solutions/): Support bioprocessing and blood filtration steps with single-use solutions to remove unwanted cell-based materials from your processes.
- [Freezing Studies](https://chartermedical.com/single-use-freezing-studies/): Optimize single-use solutions for cryopreservation by engaging in custom freezing studies.
- [Protected: Form Test](https://chartermedical.com/form-test/)
- [Why Single-use?](https://chartermedical.com/why-single-use/): In the last decade, the biopharmaceutical manufacturing landscape has undergone a notable shift with the rapid adoption of polymer-based single use technology – and there are no signs of it slowing down. By 2027, the global single use bioprocessing market is expected to reach $43.78 billion with a compound annual growth rate (CAGR) of 18.9%. But what’s driving the use of this disposable technology, and how can biopharmaceutical manufacturers find the right single use solutions for their needs?
- [DEHP-free Single-use Solutions](https://chartermedical.com/dehp-free-single-use-solutions/): Plasticizers like DEHP are found in many medical products that are used in the production and administration of new and novel therapies. REACH regulations in the European Union have restricted the use of these chemicals in lifesaving medical products, prompting the call for DEHP-free single-use solutions in biopharma production.
- [Privacy Policy](https://chartermedical.com/privacy-policy/): This Privacy Policy (the “Privacy Policy” or “Policy”) describes how Charter Medical, LLC (“Charter Medical,” “we,” “our,” or “us”) operates this Website, www.chartermedical.com (collectively the “Services”). Charter Medical, LLC is a subsidary of Solesis, LLC.
- [Cryopreservation](https://chartermedical.com/cryopreservation/): Cryopreserved materials are held with high regard, and with good reason – contained within are patient therapies, viral vectors, or influential samples used for release testing. Protecting these critical materials during freeze/thaw cycles to prevent content loss or compromised cell health begins with choosing a primary single-use container.
- [Single-use Manifold Design Services](https://chartermedical.com/single-use-manifold-design-services/): Charter Medical’s expert single-use design team has decades of experience developing and designing single-use products. Streamline your single-use manifold design to achieve the highest level of process optimization. Charter’s dedicated design team ensures:
- [About Us](https://chartermedical.com/about-us/): Lifechanging breakthroughs like cell and gene therapy are driving a medical revolution. But a lack of purpose-built development and manufacturing tools keeps these treatments from reaching more patients.
- [Operational Quality](https://chartermedical.com/operational-quality/): In recent years, biopharmaceutical developers have rapidly adopted single-use systems to improve operational efficiency, enhance product quality and consistency, and reduce costs. As demand for these systems grows, the importance of uninterrupted supply and high-quality materials have become critical factors when selecting technologies and services.
- [Blood Management](https://chartermedical.com/blood-management/): We’ve earned a reputation for our innovations by standardizing products for the blood banking industry.
- [Blood Transfusion & Cell Therapy Distributors Pennsylvania](https://chartermedical.com/blood-transfusion-cell-therapy-distributors-pennsylvania/): Charter Medical Blood Transfusion Products are sold exclusively through a specialty distribution network to hospitals, plasma centers, blood centers and healthcare providers in the USA only. The color coded map below indicates the counties covered by distributors in Pennsylvania.
- [Blood Transfusion & Cell Therapy Distributors](https://chartermedical.com/blood-transfusion-cell-therapy-distributors/): 17871 FitchIrvine, CA 92614
- [Customization Services](https://chartermedical.com/customization-services/): Collaborate with industry experts to custom-build and integrate single-use solutions into your biopharma processes to achieve more efficient workflows.
- [Cell & Gene Therapy](https://chartermedical.com/cell-gene-therapy/): AccuStrain™ 40μm & 150μm Filters are designed and packaged for bioprocessing applications, providing filtration of cell aggregates and...
- [Educational Resources](https://chartermedical.com/educational-resources/): Access Charter Medical’s resource library for expert guidance on solving industry challenges.
- [Contact Us](https://chartermedical.com/contact-us/): 3948-A Westpoint Blvd.Winston-Salem, NC 27103Toll Free: 866.458.3116Fax: 336.714.4241
- [Careers](https://chartermedical.com/careers/): Charter Medical specializes in designing and manufacturing standard and custom single-use technologies for the cell and gene therapy, bioprocessing, and blood management industries. For more than 30 years, Charter Medical’s high-quality, innovative solutions have helped industry-leading biopharmaceutical companies bring advanced, life-saving therapies to market.
- [Bioprocessing](https://chartermedical.com/bioprocessing/): Charter Medical offers bio-container systems for scalable upstream and downstream processes to meet your specific application needs.
- [Charter Medical Home Page](https://chartermedical.com/): At Charter Medical, we’re on a mission to evolve single-use processing so you can lower costs, reduce risk, make your revolutionary therapies more accessible – and transform patient outcomes.

## Categories
- [All Products](https://chartermedical.com/products/)
- [Bioprocessing](https://chartermedical.com/products/bioprocessing/)
- [Blood Management](https://chartermedical.com/products/blood-management/)
- [Cell & Gene Therapy](https://chartermedical.com/products/cell-gene-therapy/)
- [Component Processing](https://chartermedical.com/products/blood-management/component-processing/)
- [Cryopreservation](https://chartermedical.com/products/cryopreservation/)
- [DEHP-Free](https://chartermedical.com/products/dehp-free-single-use-solutions/)
- [Educational Resources](https://chartermedical.com/uncategorized/educational-resources/)
- [Events & Conferences](https://chartermedical.com/events-conferences/)
- [Filtration](https://chartermedical.com/filtration/)
- [Neonatal/Pediatric Products](https://chartermedical.com/products/blood-management/neonatal-pediatric-products/)
- [Press Releases](https://chartermedical.com/press-releases/)
- [Sampling Products](https://chartermedical.com/products/blood-management/sampling-products/)
- [Uncategorized](https://chartermedical.com/uncategorized/)